As experts in developing preclinical disease models, the scientists at Ace Therapeutics have extensive experience in customizing in vitro and in vivo disease models of gastric ulcer. Our expertise allows us to provide comprehensive disease pathology research and drug development services to our customers. Using advanced techniques and methodologies, we can accurately mimic the development of gastric ulcers and study factors such as mucosal damage, inflammation, and dysregulation of acid secretion.
Gastric ulcer refers to a sore or erosion that forms in the lining of the stomach. It is often caused by factors such as Helicobacter pylori infection, chronic use of nonsteroidal anti-inflammatory drugs (NSAIDs), or gastric acid hypersecretion. Gastric ulcers can lead to abdominal pain, bloating, and indigestion. In severe cases, they may result in complications such as bleeding or perforation.
Figure 1. The occurrence and healing of gastric ulcers (Tarnawski A.S., Ahluwalia A., 2021)
Our gastric ulcer model customization begins with selecting appropriate animal species based on research goals and physiological relevance. Options include:
We employ various methods to induce gastric ulcers in the chosen animal species:
We can use a range of detection indicators and assessment methods to verify gastric ulcer models.
Our gastric ulcer model customization service enables comprehensive basic pathology research in gastroenterology, allowing for in-depth studies of ulcer mechanisms, inflammatory responses, tissue damage progression, and genetic factors influencing ulcer development. We can help researchers investigate the cellular and molecular pathways involved in gastric ulcer formation, facilitating a better understanding of disease progression and potential therapeutic targets.
We leverage our customized disease models to help customers identify novel therapeutic targets and pathways that play key roles in ulcer healing, acid suppression, anti-inflammatory effects, and mucosal protection. Through mechanistic investigations and biomarker discovery, we uncover potential drug targets that can be further explored for developing innovative treatments targeting specific pathology of gastric ulcer.
Our gastric ulcer model customization service plays a crucial role in our customers' drug development endeavors by providing a robust platform for evaluating potential therapeutic interventions. We conduct comprehensive pharmacodynamic and pharmacokinetic evaluations, providing valuable insights into drug bioavailability, tissue distribution, and clearance rates.
Ace Therapeutics offers unparalleled gastric ulcer model customization services designed to meet the diverse research and drug development needs of our customers. With meticulous attention to detail, we tailor animal models to mimic gastric ulcer pathology, providing a robust platform for gastric ulcer pathology research and drug development. Contact us today to explore how our services can support and enhance your gastroenterology research endeavors.
Our products and services are for research use only and can not be used for diagnostic or other purposes.